XRAY · Insider Trading
DENTSPLY SIRONA Inc.
Every open-market purchase and sale reported by XRAY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Jonathan Jay Mazelsky | Director | A | +3,323 deriv. | — |
| 2026-08-12 | John C. Fortson | EVP & CFO | A | +24,014 | — |
| 2026-08-11 | Andrea L. Frohning | SVP, CHRO | F | −802 | −$9.72K |
| 2026-07-01 | Jonathan Jay Mazelsky | Director | A | +2,841 deriv. | — |
| 2026-06-18 | Jonathan Jay Mazelsky | Director | Buy | +10,000 | +$101.40K |
| 2026-06-16 | Clyde Hosein | Director | Buy | +6,500 | +$64.90K |
| 2026-06-15 | Michael J Barber | Director | Buy | +15,175 | +$150.00K |
| 2026-06-15 | Brian T Gladden | Director | Buy | +9,985 | +$100.00K |
| 2026-06-15 | Brian P McKeon | Director | Buy | +10,000 | +$101.20K |
| 2026-06-15 | Betsy D Holden | Director | Buy | +10,086 | +$99.69K |
| 2026-06-15 | Jonathan Jay Mazelsky | Director | A | +10,000 | +$101.40K |
| 2026-06-05 | Michael J Barber | Director | A | +22,822 | — |
| 2026-06-05 | James D Forbes | Director | A | +28,887 | — |
| 2026-06-05 | Brian T Gladden | Director | A | +22,822 | — |
| 2026-06-05 | Betsy D Holden | Director | A | +22,822 | — |
| 2026-06-05 | Clyde Hosein | Director | A | +22,822 | — |
| 2026-06-05 | Jonathan Jay Mazelsky | Director | A | +22,822 | — |
| 2026-06-05 | Brian P McKeon | Director | A | +28,887 | — |
| 2026-06-05 | Leslie F Varon | Director | A | +22,822 | — |
| 2026-06-05 | Janet S. Vergis | Director | A | +22,822 | — |
| 2026-06-05 | Donald Zurbay | Director | A | +22,822 | — |
| 2026-06-05 | Gregory T Lucier | Director | MIXED | +38,382 | — |
| 2026-05-26 | Daniel T Scavilla | President, CEO & Member of BOD | F | −4,095 | −$41.81K |
| 2026-04-02 | Jonathan Jay Mazelsky | Director | A | +2,644 deriv. | — |
| 2026-03-12 | Kevin Czerney | VP, Chief Accounting Officer | A | +2,853 deriv. | — |
| 2026-03-12 | Aldo Mariano Roberto Denti | EVP, Chief Commercial Officer | A | +829 deriv. | — |
| 2026-03-12 | Daniel T Scavilla | President, CEO & Member of BOD | A | +3,554 deriv. | — |
| 2026-03-09 | James D Forbes | Director | Buy | +5,000 | +$62.40K |
| 2026-03-09 | Gregory T Lucier | Director | Buy | +15,000 | +$186.68K |
| 2026-03-06 | Robert Anthony Johnson | SVP, Chief Supply Chain Office | A | +471,400 deriv. | — |
| 2026-03-06 | Robert Anthony Johnson | SVP, Chief Supply Chain Office | A | +44,643 | — |
| 2026-03-06 | Daniel T Scavilla | President, CEO & Member of BOD | A | +145,089 | — |
| 2026-03-06 | Aldo Mariano Roberto Denti | EVP, Chief Commercial Officer | A | +59,524 | — |
| 2026-03-06 | Andrea L. Frohning | SVP, CHRO | A | +26,786 | — |
| 2026-03-06 | Kevin Czerney | VP, Chief Accounting Officer | A | +13,690 | — |
| 2026-03-05 | Kevin Czerney | VP, Chief Accounting Officer | F | −2,052 | −$27.34K |
| 2026-03-05 | Andrea L. Frohning | SVP, CHRO | F | −5,657 | −$75.33K |
| 2026-03-05 | Robert Anthony Johnson | SVP, Chief Supply Chain Office | F | −8,736 | −$116.33K |
| 2026-03-03 | James D Forbes | Director | Buy | +5,000 | +$67.34K |
| 2026-03-03 | Kevin Czerney | VP, Chief Accounting Officer | A | +1,478 | — |
| 2026-03-03 | Andrea L. Frohning | SVP, CHRO | A | +8,861 | — |
| 2026-03-03 | Robert Anthony Johnson | SVP, Chief Supply Chain Office | A | +9,599 | — |
| 2026-03-03 | Gregory T Lucier | Director | Buy | +50,000 | +$707.38K |
| 2026-02-26 | Daniel T Scavilla | President, CEO & Member of BOD | F | −1,194 | −$15.70K |
| 2026-01-27 | Donald Zurbay | Director | A | +6,871 | — |
| 2026-01-13 | Michael J Barber | Director | A | +245 | — |
| 2026-01-13 | Kevin Czerney | VP, Chief Accounting Officer | A | +262 | — |
| 2026-01-13 | Willie A Deese | Director | A | +201 | — |
| 2026-01-13 | Andrea L. Frohning | SVP, CHRO | A | +392 | — |
| 2026-01-13 | Brian T Gladden | Director | A | +314 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Simon D Campion | President, CEO | 239,837 | $2.30M |
| Robert Anthony Johnson | SVP, Chief Supply Chain Office | 161,819 | $1.56M |
| Daniel T Scavilla | President, CEO & Member of BOD | 157,754 | $1.52M |
| Gregory T Lucier | Director | 101,665 | $977.00K |
| Betsy D Holden | Director | 87,528 | $841.14K |
| Richard C Rosenzweig | EVP, Corp Dev, GC & Secretary | 85,183 | $818.61K |
| Leslie F Varon | Director | 80,364 | $772.30K |
| Clyde Hosein | Director | 70,575 | $678.23K |
| Janet S. Vergis | Director | 67,324 | $646.98K |
| Andrea L. Frohning | SVP, CHRO | 63,190 | $607.26K |
| Brian T Gladden | Director | 61,848 | $594.36K |
| Jonathan Jay Mazelsky | Director | 61,668 | $592.63K |
| Aldo Mariano Roberto Denti | EVP, Chief Commercial Officer | 59,524 | $572.03K |
| Willie A Deese | Director | 57,748 | $554.96K |
| Michael J Barber | Director | 55,943 | $537.61K |
| Matthew E Garth | EVP & CFO | 44,011 | $422.95K |
| Kevin Czerney | VP, Chief Accounting Officer | 41,268 | $396.59K |
| James D Forbes | Director | 38,887 | $373.70K |
| Brian P McKeon | Director | 38,887 | $373.70K |
| Donald Zurbay | Director | 29,693 | $285.35K |
| John C. Fortson | EVP & CFO | 24,014 | $230.77K |
| Ilse Dorothea Wenzel | Director | 16,551 | $159.06K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the XRAY quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.